The Words You Will Hear

Part of Understanding Cancer Trials: Starting from where you are.

About 4 minutes. Free, in your language, no account needed.

This is general education about clinical research — not medical advice, and not a way to join a study. Talk to your own doctor about your situation.

Research has its own vocabulary. Most of it is ordinary once someone explains it.

Here are the words that come up most often. You do not need to memorize them. You can come back to this page whenever one of them appears.

Words about the study itself

• Protocol — the written plan for the study. What will happen, to whom, in what order.
• Sponsor — the organization that is responsible for the study. It may be a company, a hospital, a university, or a government body.
• Site — the hospital or clinic where the study actually happens.
• Investigator — the doctor who is responsible for running the study at that site. The principal investigator is the one in overall charge there.
• Endpoint — the specific thing the study measures to answer its question. The study decides its endpoints in advance.

Words about how people are divided up

• Arm — one group within the study. A study with two arms has two groups being compared.
• Standard of care — the treatment that is normally given for your situation today, based on current evidence.
• Randomization — deciding by chance, usually by computer, which arm each person joins.
• Blinding — keeping people from knowing which arm someone is in, so that expectations do not affect the results. In a double-blind study, neither you nor your study doctor knows.
• Placebo — something that looks like the treatment but contains no active medicine.

Words about who can take part

• Eligibility criteria — the written list of who can and cannot join a particular study.
• Inclusion criteria — the things that must be true for you to join.
• Exclusion criteria — the things that mean you cannot join.
• Screening — the tests and checks done to see whether the criteria are met, before anyone enrolls.

Words about safety and rights

• Informed consent — the process of being helped to understand the study, so you can freely decide. It is a conversation, not only a form.
• Ethics committee or IRB — the independent group that reviews and approves the study before it starts, to protect participants.
• Adverse event — any unwanted medical problem that happens to someone during a study. It is recorded whether or not anyone thinks the study caused it.
• Serious adverse event — an adverse event that is severe by defined rules, such as one that leads to a hospital stay.
• Withdraw — to stop taking part. You may do this at any time.

Words you may hear in cancer studies in particular

• Biomarker — something measurable in your body, often in blood or in a tumor sample, that gives information about the disease.
• Tumor response — a measurement of whether a tumor has shrunk, stayed the same, or grown, judged by defined rules on a scan.
• Line of treatment — where a treatment sits in the usual order. "First line" is what is normally tried first.
• Follow-up — the period after the main treatment part of the study, when the team keeps checking how you are.

If a word is confusing

Ask. Ask again if the second explanation is no clearer than the first.

Confusion is information. It tells the team that the explanation has not landed yet, and helping it land is their job, not yours. A good team will welcome the question and will not think less of you for it.

You can also ask them to write the word down, or to explain it to someone who is with you.

In short

• The vocabulary of research is small, and it can all be said in plain words.
• Arm, randomization, blinding and placebo describe how people are grouped and compared.
• Eligibility criteria are the written rules about who a study can include.
• Informed consent is a conversation, and an ethics committee reviews the study before it starts.
• If a word is unclear, asking is the right move, and the team owes you a clearer answer.